SCHEMBL17367490

SCHEMBL17367490

CC(=O)C1(c2ccc(-c3ccc(-c4sc(F)cc4C(=O)O)cc3)cc2)CC1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APP P05067 6/20 0.37
CYP2C19 P33261 5/20 0.37
CYP2C9 P11712 4/20 0.37
CYP2D6 P10635 2/20 0.37
AKR1C3 P42330 4/20 0.36
AKR1C2 P52895 4/20 0.36
AKR1C1 Q04828 3/20 0.36
AKR1B10 O60218 1/20 0.36
AKR1C4 P17516 1/20 0.36
PRKAB2 O43741 7/20 0.35
PRKAG1 P54619 7/20 0.35
PRKAA2 P54646 7/20 0.35
PRKAA1 Q13131 7/20 0.35
PRKAG3 Q9UGI9 7/20 0.35
PRKAG2 Q9UGJ0 7/20 0.35
PRKAB1 Q9Y478 7/20 0.35
CYP3A4 P08684 5/20 0.34
PSEN1 P49768 1/20 0.33
PSEN2 P49810 1/20 0.33
APH1B Q8WW43 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17367484 0.91 APP (0.35) APPCYP2C19CYP2C9CYP2D6AKR1C3
SCHEMBL17367491 0.85 APP (0.35) APPCYP2C19CYP2C9CYP2D6AKR1C3
SCHEMBL17367487 0.85 PRKAB2 (0.35) APPCYP2C19CYP2C9CYP2D6AKR1C3
SCHEMBL17367489 0.85 PRKAB2 (0.40) APPCYP2C19CYP2C9CYP2D6AKR1C3
SCHEMBL15854204 0.83 OPRM1 (0.46) OPRD1
SCHEMBL17367485 0.76 CHEK1 (0.35) APPCYP2C19CYP2C9CYP2D6AKR1C3
SCHEMBL17367479 0.75 MAPT (0.36) APPCYP2C19CYP2C9CYP2D6AKR1C3
SCHEMBL17367481 0.75 PTGS1 (0.30) APPCYP2C19CYP2C9CYP2D6CYP3A4
SCHEMBL15853727 0.74 APP (0.47) APPCYP2C19CYP2C9CYP2D6AKR1C3
SCHEMBL15854152 0.73 APP (0.47) APPCYP2C19CYP2C9CYP2D6AKR1C3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150376160-A1 HALOGEN-SUBSTITUTED HETEROCYCLIC COMPOUND UBE INDUSTRIES, LTD. (JP) 2015-12-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150376160-A1 HALOGEN-SUBSTITUTED HETEROCYCLIC COMPOUND LPAR3, LPAR1, LPAR2 APP 4316/4885CYP2C19 2055/4885CYP2C9 2611/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.